A game-changing therapy for type 2 diabetes? Plus, the latest on predictive low glucose suspend, faster insulin, and a better Bydureon.

The technology giant, Google recently announced that it is working to develop a contact lens that could non-invasively monitor glucose levels from tears. The smart...

On February 22, Slow Food San Francisco hosted the annual Childhood Obesity Bay Area Conference, which featured Dr. Robert Lustig of the University of California, San...

What apps are best for diabetes? What we learned at this year’s AADE 2013.

Last month, in early September, results from the DPP-4 inhibitor cardiovascular outcomes trials SAVOR-TIMI 53 (for Bristol Myers Squibb and AstraZeneca’s Onglyza) and...

On January 7, the FDA announced updated standards for the accuracy of blood glucose monitors for use in both the home and healthcare facility settings. These standards...

The first quarter of 2013 has been eventful for Johnson & Johnson Diabetes Care. Animas Corporation submitted the Animas Vibe insulin pump to the FDA, integrated...

Five things people with diabetes need to know about the Affordable Care Act.

Xeris announced last month the beginning of its phase 2 trial of a room temperature stabilized glucagon. The trial will compare Xeris’ glucagon to Eli Lilly’s glucagon...

On March 4, Medtronic announced the creation of a new pilot program with Aetna to provide an insulin pump to up to 300 fully insured members with uncontrolled type 2...

Samepage Health launched VisitPrep , a tool that helps patients organize their medical questions before going to their healthcare provider (HCP). The tool asks for the...

Downloading data, CGMs and insurance coverage, and how the Mediterranean diet is good for your heart.

Last month, the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) released its safety review of incretin-based therapies for diabetes. It...

MannKind’s inhalable ultra-rapid-acting insulin Afrezza has its day at the FDA – find out what it can do for patients and how to speak up!

On January 8, the FDA approved Farxiga (dapaglifozin) for the treatment of type 2 diabetes. The drug is called Forxiga in Europe, where it has been approved since...

On April 3, an FDA Advisory Committee voted an overwhelming 13-1 in favor of approving MannKind’s ultra-rapid-acting inhaled insulin Afrezza for type 1 diabetes. The...

An open letter to the FDA’s Dr. Margaret Hamburg from diaTribe .

This November will be the third annual World Diabetes Day Postcard Exchange, where people from around the world will send and receive handmade postcards to celebrate...

On January 13, J&J LifeScan announced the launch of the OneTouch VerioSync blood glucose meter in the US. The meter sends blood glucose readings wirelessly (via...

On April 17, Abbott announced a recall of the FreeStyle InsuLinx blood glucose meters due to software issues for readings of 1,024 mg/dl and above. The problem is...